Procedure for Prequalification of Pharmaceutical Products
OFFICIAL SOURCE FACTS / REQUIREMENT FRAMEWORK
What you need to know
TRS 1067 Annex 4, published 9 June 2026, describes assessment of eligible pharmaceutical products against WHO requirements.
Assessment may cover dossiers, API information, manufacturing-site and relevant clinical/CRO inspections, quality-control testing and WHO GMP. Listing is not national market authorization or WHO endorsement.
This summary is not a complete regulatory checklist. Applicability, conditions and exclusions remain governed by the original official document.
Who is affected
Manufacturers
Suppliers / Wholesale Distributors
Exporters
Regulatory Teams
Quality Teams
Business Development
Procurement Teams
PHARMA GATE INTERPRETATION — NOT AN OFFICIAL REQUIREMENT
Pharma Gate Intelligence
Start with product eligibility and evidence gaps. Prequalification does not automatically register a product in Egypt or any other country.
Business impact
Product-specific evidence and supplier requirements can affect planning and participation. Neither national authorization nor an award is guaranteed.
RECOMMENDED ACTION — NOT A REGULATORY DETERMINATION
What to check
Current expression of interest and exact product scope
Applicable assessment pathway and supporting evidence
National registration requirements separately
Recommended next step
Review the applicable current WHO documents and the specific product or procurement notice with qualified professional support.
Independent professional support pathways. Pharma Gate does not assess eligibility, certify suppliers or submit applications to WHO.
VERIFIED SOURCE GOVERNANCE
Official facts are attributed to issuing authorities. Pharma Gate analysis and recommended actions are clearly separated.
How we verify intelligence
Official facts are attributed to the issuing organization. Pharma Gate interpretation and recommended actions are separate editorial layers, not legal requirements or regulatory approval. Sources are prioritized: national regulators, WHO and recognized intergovernmental bodies, official procurement organizations, then other official governmental or institutional sources.
Publication records retain source title, version, issue date, verification date, country, sector and status. Draft / Public Consultation is distinct from Current. Superseded and Archived records do not represent current requirements. A verification date records the review performed; it is not an assurance of continuous monitoring. Always check the latest official source before acting.
WHO Prequalification of Pharmaceutical Products | Pharma Gate | Pharma Gate
